Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) closed at $16.59 down -0.60% from its previous closing price of $16.69. In other words, the price has decreased by -$0.60 from its previous closing price. On the day, 6.88 million shares were traded. TEVA stock price reached its highest trading level at $16.67 during the session, while it also had its lowest trading level at $16.4.
Ratios:
For a deeper understanding of Teva- Pharmaceutical Industries Ltd. ADR’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.66 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 6.86. For the most recent quarter (mrq), Quick Ratio is recorded 0.61 and its Current Ratio is at 0.89. In the meantime, Its Debt-to-Equity ratio is 3.18 whereas as Long-Term Debt/Eq ratio is at 2.75.
On March 08, 2024, JP Morgan Upgraded its rating to Neutral which previously was Underweight but kept the price unchanged to $14.
Piper Sandler Upgraded its Neutral to Overweight on February 12, 2024, whereas the target price for the stock was revised from $12 to $19.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 20 ’24 when Fox Christine sold 19,388 shares for $16.87 per share. The transaction valued at 327,085 led to the insider holds 44,104 shares of the business.
Fox Christine bought 19,388 shares of TEVA for $327,085 on Nov 20 ’24. On Aug 12 ’24, another insider, Daniell Richard, who serves as the Exec. VP, European Commercial of the company, sold 98,943 shares for $17.30 each. As a result, the insider received 1,711,447 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TEVA now has a Market Capitalization of 18797299712 and an Enterprise Value of 35185606656. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.12 while its Price-to-Book (P/B) ratio in mrq is 3.10. Its current Enterprise Value per Revenue stands at 2.098 whereas that against EBITDA is 7.352.
Stock Price History:
Over the past 52 weeks, TEVA has reached a high of $19.31, while it has fallen to a 52-week low of $9.35. The 50-Day Moving Average of the stock is -5.85%, while the 200-Day Moving Average is calculated to be 2.32%.
Shares Statistics:
For the past three months, TEVA has traded an average of 6.81M shares per day and 8229560 over the past ten days. A total of 1.13B shares are outstanding, with a floating share count of 1.13B. Insiders hold about 0.01% of the company’s shares, while institutions hold 56.95% stake in the company. Shares short for TEVA as of 1730332800 were 18094518 with a Short Ratio of 2.66, compared to 1727654400 on 24492294. Therefore, it implies a Short% of Shares Outstanding of 18094518 and a Short% of Float of 1.6099999999999999.
Dividends & Splits
The stock’s 5-year Average Dividend Yield is 2.95.
